Announced details
Selection of stocks listed on the TSE Prime Market, capital profitability, market valuation, and evaluation of corporate value and value creation
Sumitomo Pharma Co., Ltd. was selected as a constituent of the index. Capital, personnel, and business relationships are Not disclosed.
The company that developed the JPX Prime 150 Index. Other information, including its location, representative, capital, and year of establishment, is Not disclosed.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
The periodic selection results published by JPX Market Innovation & Research, Inc. for the JPX Prime 150 Index and the index details page (https://www.jpx.co.jp/markets/indices/jpx-prime150/index.html)
| Item | Details |
|---|---|
| Names of Products / Services Covered | JPX Prime 150 Index |
| Counterparty | JPX Market Innovation & Research, Inc. |
| Counterparty overview | The company that developed the JPX Prime 150 Index. Other information, including its location, representative, capital, and year of establishment, is Not disclosed. |
| Relationship with the Company | Sumitomo Pharma Co., Ltd. was selected as a constituent of the index. Capital, personnel, and business relationships are Not disclosed. |
| Launch date | 31 August 2026 (scheduled effective date of the periodic rebalancing) |
| Applicable area | Selection of stocks listed on the TSE Prime Market, capital profitability, market valuation, and evaluation of corporate value and value creation |
| Source | The periodic selection results published by JPX Market Innovation & Research, Inc. for the JPX Prime 150 Index and the index details page (https://www.jpx.co.jp/markets/indices/jpx-prime150/index.html) |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.JPX Market Innovation & Research, Inc. selects constituents based on capital profitability derived from financial performance and market valuation that also incorporates forward-looking and non-financial information.